Plant-Derived Recombinant Human Serum Albumin - Global and China Top Players Market Share and Ranking 2023
According to latest Research, the global market for Plant-Derived Recombinant Human Serum Albumin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Plant-Derived Recombinant Human Serum Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Plant-Derived Recombinant Human Serum Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Scientific Research grew percent to account for percent of the total market sales, and Pharmaceutical grew percent.
Plant-Derived Recombinant Human Serum Albumin is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA).
This report studies and analyses global Plant-Derived Recombinant Human Serum Albumin status and future trends, helps the client to determine the Plant-Derived Recombinant Human Serum Albumin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Plant-Derived Recombinant Human Serum Albumin, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Plant-Derived Recombinant Human Serum Albumin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Units)
(2) Global Plant-Derived Recombinant Human Serum Albumin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(3) China Plant-Derived Recombinant Human Serum Albumin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Units)
(4) Global Plant-Derived Recombinant Human Serum Albumin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Plant-Derived Recombinant Human Serum Albumin key producing regions, capacity, production, and year over year growth
(6) Plant-Derived Recombinant Human Serum Albumin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Albumedix
Merck
Ventria (InVitria)
Novozymes Biopharma
CSL Limited
LGC Group
Bipha Ayurveda (IHI Corporation)
Wuhan Healthgen Biotechnology Corp.
Takeda Pharmaceutical Company Limited
NCPC
Oryzogen
HiMedia
Grifols
Aspira Chemical
Market segment by Type, covers
OsrHSA
ScrHSA
Market segment by Application, can be divided into
Scientific Research
Pharmaceutical
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Plant-Derived Recombinant Human Serum Albumin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Plant-Derived Recombinant Human Serum Albumin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Plant-Derived Recombinant Human Serum Albumin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Plant-Derived Recombinant Human Serum Albumin, percent & CAGR, 2018-2029
Chapter 5: Plant-Derived Recombinant Human Serum Albumin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Plant-Derived Recombinant Human Serum Albumin Definition
1.2 Global Plant-Derived Recombinant Human Serum Albumin Market Size and Forecast
1.2.1 By Consumption Value, Global Plant-Derived Recombinant Human Serum Albumin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Plant-Derived Recombinant Human Serum Albumin Market Size，2018-2029
1.2.3 Global Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP)，2018-2029
1.3 China Plant-Derived Recombinant Human Serum Albumin Market Size and Forecast
1.3.1 By Consumption Value, China Plant-Derived Recombinant Human Serum Albumin Market Size，2018-2029
1.3.2 By Sales Quantity, China Plant-Derived Recombinant Human Serum Albumin Market Size，2018-2029
1.3.3 China Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Plant-Derived Recombinant Human Serum Albumin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Plant-Derived Recombinant Human Serum Albumin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Plant-Derived Recombinant Human Serum Albumin Market Share in Global, 2018-2029
1.4.3 Plant-Derived Recombinant Human Serum Albumin Market Size: China VS Global, 2018-2029
1.5 Plant-Derived Recombinant Human Serum Albumin Market Dynamics
1.5.1 Plant-Derived Recombinant Human Serum Albumin Market Drivers
1.5.2 Plant-Derived Recombinant Human Serum Albumin Market Restraints
1.5.3 Plant-Derived Recombinant Human Serum Albumin Industry Trends
1.5.4 Plant-Derived Recombinant Human Serum Albumin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Plant-Derived Recombinant Human Serum Albumin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Plant-Derived Recombinant Human Serum Albumin, Global Market Share by Company, 2018-2023
2.3 Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Plant-Derived Recombinant Human Serum Albumin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Plant-Derived Recombinant Human Serum Albumin Concentration Ratio
2.6 Global Plant-Derived Recombinant Human Serum Albumin Mergers & Acquisitions, Expansion Plans
2.7 Global Plant-Derived Recombinant Human Serum Albumin Manufacturers Product Type
2.8 Head Office and Plant-Derived Recombinant Human Serum Albumin Production Site of Key Manufacturer
2.9 Plant-Derived Recombinant Human Serum Albumin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Plant-Derived Recombinant Human Serum Albumin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Plant-Derived Recombinant Human Serum Albumin, China Market Share by Company, 2018-2023
3.3 China Plant-Derived Recombinant Human Serum Albumin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Plant-Derived Recombinant Human Serum Albumin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Plant-Derived Recombinant Human Serum Albumin Capacity by Region
4.3 Global Plant-Derived Recombinant Human Serum Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Plant-Derived Recombinant Human Serum Albumin Production by Region, 2018-2029
4.5 Global Plant-Derived Recombinant Human Serum Albumin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Plant-Derived Recombinant Human Serum Albumin Industry Chain
5.2 Plant-Derived Recombinant Human Serum Albumin Upstream Analysis
5.2.1 Plant-Derived Recombinant Human Serum Albumin Core Raw Materials
5.2.2 Main Manufacturers of Plant-Derived Recombinant Human Serum Albumin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Plant-Derived Recombinant Human Serum Albumin Production Mode
5.6 Plant-Derived Recombinant Human Serum Albumin Procurement Model
5.7 Plant-Derived Recombinant Human Serum Albumin Industry Sales Model and Sales Channels
5.7.1 Plant-Derived Recombinant Human Serum Albumin Sales Model
5.7.2 Plant-Derived Recombinant Human Serum Albumin Typical Distributors
6 Sights by Type
6.1 Plant-Derived Recombinant Human Serum Albumin Classification
6.1.1 OsrHSA
6.1.2 ScrHSA
6.2 By Type, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029
6.4 By Type, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029
6.5 By Type, Global Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Plant-Derived Recombinant Human Serum Albumin Segment by Application
7.1.1 Scientific Research
7.1.2 Pharmaceutical
7.1.3 Others
7.2 By Application, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029
7.4 By Application, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029
7.5 By Application, Global Plant-Derived Recombinant Human Serum Albumin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029
8.3 By Region, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Plant-Derived Recombinant Human Serum Albumin & Forecasts, 2018-2029
8.4.2 By Country, North America Plant-Derived Recombinant Human Serum Albumin Market Size Market Share
8.5 Europe
8.5.1 Europe Plant-Derived Recombinant Human Serum Albumin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Plant-Derived Recombinant Human Serum Albumin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Size Market Share
8.7 South America
8.7.1 South America Plant-Derived Recombinant Human Serum Albumin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Plant-Derived Recombinant Human Serum Albumin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Plant-Derived Recombinant Human Serum Albumin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029
9.3 By Country, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.4.2 By Type, U.S. Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.5.2 By Type, Europe Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.6.2 By Type, China Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.7.2 By Type, Japan Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.8.2 By Type, South Korea Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.10.2 By Type, India Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Albumedix
10.1.1 Albumedix Company Information, Head Office, Market Area, and Industry Position
10.1.2 Albumedix Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.1.3 Albumedix Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Albumedix Company Profile and Main Business
10.1.5 Albumedix Recent Developments
10.2 Merck
10.2.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.2.2 Merck Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.2.3 Merck Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck Company Profile and Main Business
10.2.5 Merck Recent Developments
10.3 Ventria (InVitria)
10.3.1 Ventria (InVitria) Company Information, Head Office, Market Area, and Industry Position
10.3.2 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.3.3 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Ventria (InVitria) Company Profile and Main Business
10.3.5 Ventria (InVitria) Recent Developments
10.4 Novozymes Biopharma
10.4.1 Novozymes Biopharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.4.3 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Novozymes Biopharma Company Profile and Main Business
10.4.5 Novozymes Biopharma Recent Developments
10.5 CSL Limited
10.5.1 CSL Limited Company Information, Head Office, Market Area, and Industry Position
10.5.2 CSL Limited Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.5.3 CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 CSL Limited Company Profile and Main Business
10.5.5 CSL Limited Recent Developments
10.6 LGC Group
10.6.1 LGC Group Company Information, Head Office, Market Area, and Industry Position
10.6.2 LGC Group Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.6.3 LGC Group Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 LGC Group Company Profile and Main Business
10.6.5 LGC Group Recent Developments
10.7 Bipha Ayurveda (IHI Corporation)
10.7.1 Bipha Ayurveda (IHI Corporation) Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.7.3 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bipha Ayurveda (IHI Corporation) Company Profile and Main Business
10.7.5 Bipha Ayurveda (IHI Corporation) Recent Developments
10.8 Wuhan Healthgen Biotechnology Corp.
10.8.1 Wuhan Healthgen Biotechnology Corp. Company Information, Head Office, Market Area, and Industry Position
10.8.2 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.8.3 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Wuhan Healthgen Biotechnology Corp. Company Profile and Main Business
10.8.5 Wuhan Healthgen Biotechnology Corp. Recent Developments
10.9 Takeda Pharmaceutical Company Limited
10.9.1 Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area, and Industry Position
10.9.2 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.9.3 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Takeda Pharmaceutical Company Limited Company Profile and Main Business
10.9.5 Takeda Pharmaceutical Company Limited Recent Developments
10.10 NCPC
10.10.1 NCPC Company Information, Head Office, Market Area, and Industry Position
10.10.2 NCPC Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.10.3 NCPC Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 NCPC Company Profile and Main Business
10.10.5 NCPC Recent Developments
10.11 Oryzogen
10.11.1 Oryzogen Company Information, Head Office, Market Area, and Industry Position
10.11.2 Oryzogen Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.11.3 Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Oryzogen Company Profile and Main Business
10.11.5 Oryzogen Recent Developments
10.12 HiMedia
10.12.1 HiMedia Company Information, Head Office, Market Area, and Industry Position
10.12.2 HiMedia Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.12.3 HiMedia Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 HiMedia Company Profile and Main Business
10.12.5 HiMedia Recent Developments
10.13 Grifols
10.13.1 Grifols Company Information, Head Office, Market Area, and Industry Position
10.13.2 Grifols Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.13.3 Grifols Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Grifols Company Profile and Main Business
10.13.5 Grifols Recent Developments
10.14 Aspira Chemical
10.14.1 Aspira Chemical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
10.14.3 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Aspira Chemical Company Profile and Main Business
10.14.5 Aspira Chemical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Plant-Derived Recombinant Human Serum Albumin Market Restraints
Table 3. Plant-Derived Recombinant Human Serum Albumin Market Trends
Table 4. Plant-Derived Recombinant Human Serum Albumin Industry Policy
Table 5. Global Plant-Derived Recombinant Human Serum Albumin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Plant-Derived Recombinant Human Serum Albumin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 8. Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Plant-Derived Recombinant Human Serum Albumin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Plant-Derived Recombinant Human Serum Albumin Mergers & Acquisitions, Expansion Plans
Table 12. Global Plant-Derived Recombinant Human Serum Albumin Manufacturers Product Type
Table 13. Head Office and Plant-Derived Recombinant Human Serum Albumin Production Site of Key Manufacturer
Table 14. Plant-Derived Recombinant Human Serum Albumin Capacity of Major Manufacturers and Future Plan
Table 15. China Plant-Derived Recombinant Human Serum Albumin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Plant-Derived Recombinant Human Serum Albumin Sales Quantity by Company, (2018-2023) & (Units), Ranked Based on Sales in 2022
Table 17. China Plant-Derived Recombinant Human Serum Albumin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Plant-Derived Recombinant Human Serum Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029, (Units)
Table 19. Global Plant-Derived Recombinant Human Serum Albumin Production by Region, 2018-2023, (Units)
Table 20. Global Plant-Derived Recombinant Human Serum Albumin Production Forecast by Region, 2024-2029, (Units)
Table 21. Global Key Players of Plant-Derived Recombinant Human Serum Albumin Upstream (Raw Materials)
Table 22. Global Plant-Derived Recombinant Human Serum Albumin Typical Customers
Table 23. Plant-Derived Recombinant Human Serum Albumin Typical Distributors
Table 24. By Type, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029, (Units)
Table 29. By Country, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, 2018-2029, (Units)
Table 33. By Country, Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity Market Share, 2018-2029
Table 34. Albumedix Company Information, Head Office, Market Area, and Industry Position
Table 35. Albumedix Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 36. Albumedix Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Albumedix Company Profile and Main Business
Table 38. Albumedix Recent Developments
Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 41. Merck Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Ventria (InVitria) Company Information, Head Office, Market Area, and Industry Position
Table 45. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 46. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Ventria (InVitria) Company Profile and Main Business
Table 48. Ventria (InVitria) Recent Developments
Table 49. Novozymes Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 50. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 51. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novozymes Biopharma Company Profile and Main Business
Table 53. Novozymes Biopharma Recent Developments
Table 54. CSL Limited Company Information, Head Office, Market Area, and Industry Position
Table 55. CSL Limited Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 56. CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. CSL Limited Company Profile and Main Business
Table 58. CSL Limited Recent Developments
Table 59. LGC Group Company Information, Head Office, Market Area, and Industry Position
Table 60. LGC Group Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 61. LGC Group Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. LGC Group Company Profile and Main Business
Table 63. LGC Group Recent Developments
Table 64. Bipha Ayurveda (IHI Corporation) Company Information, Head Office, Market Area, and Industry Position
Table 65. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 66. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bipha Ayurveda (IHI Corporation) Company Profile and Main Business
Table 68. Bipha Ayurveda (IHI Corporation) Recent Developments
Table 69. Wuhan Healthgen Biotechnology Corp. Company Information, Head Office, Market Area, and Industry Position
Table 70. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 71. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Wuhan Healthgen Biotechnology Corp. Company Profile and Main Business
Table 73. Wuhan Healthgen Biotechnology Corp. Recent Developments
Table 74. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area, and Industry Position
Table 75. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 76. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Takeda Pharmaceutical Company Limited Company Profile and Main Business
Table 78. Takeda Pharmaceutical Company Limited Recent Developments
Table 79. NCPC Company Information, Head Office, Market Area, and Industry Position
Table 80. NCPC Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 81. NCPC Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. NCPC Company Profile and Main Business
Table 83. NCPC Recent Developments
Table 84. Oryzogen Company Information, Head Office, Market Area, and Industry Position
Table 85. Oryzogen Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 86. Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Oryzogen Company Profile and Main Business
Table 88. Oryzogen Recent Developments
Table 89. HiMedia Company Information, Head Office, Market Area, and Industry Position
Table 90. HiMedia Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 91. HiMedia Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. HiMedia Company Profile and Main Business
Table 93. HiMedia Recent Developments
Table 94. Grifols Company Information, Head Office, Market Area, and Industry Position
Table 95. Grifols Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 96. Grifols Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Grifols Company Profile and Main Business
Table 98. Grifols Recent Developments
Table 99. Aspira Chemical Company Information, Head Office, Market Area, and Industry Position
Table 100. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Models, Specifications, and Application
Table 101. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Aspira Chemical Company Profile and Main Business
Table 103. Aspira Chemical Recent Developments
List of Figures
Figure 1. Plant-Derived Recombinant Human Serum Albumin Picture
Figure 2. Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Plant-Derived Recombinant Human Serum Albumin Sales Quantity, (Units) & (2018-2029)
Figure 4. Global Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Plant-Derived Recombinant Human Serum Albumin Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Plant-Derived Recombinant Human Serum Albumin Sales Quantity (Units) & (2018-2029)
Figure 7. China Plant-Derived Recombinant Human Serum Albumin Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Plant-Derived Recombinant Human Serum Albumin Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Plant-Derived Recombinant Human Serum Albumin Market Share of Global, 2018-2029
Figure 10. Global Plant-Derived Recombinant Human Serum Albumin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Plant-Derived Recombinant Human Serum Albumin Key Participants, Market Share, 2022
Figure 12. Global Plant-Derived Recombinant Human Serum Albumin Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Plant-Derived Recombinant Human Serum Albumin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Plant-Derived Recombinant Human Serum Albumin Production Market Share & Forecast by Region, 2018-2029
Figure 15. Plant-Derived Recombinant Human Serum Albumin Industry Chain
Figure 16. Plant-Derived Recombinant Human Serum Albumin Procurement Model
Figure 17. Plant-Derived Recombinant Human Serum Albumin Sales Model
Figure 18. Plant-Derived Recombinant Human Serum Albumin Sales Channels, Direct Sales, and Distribution
Figure 19. OsrHSA
Figure 20. ScrHSA
Figure 21. By Type, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Plant-Derived Recombinant Human Serum Albumin Consumption Value Market Share, 2018-2
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|